
New York’s Pathos AI Raises $237 Million for AI Drug Development
Pathos AI announced a $237 million Series E on October 23, alongside BMS and Tempus partnerships for AI-assisted drug research.
Continue Reading
Pathos AI announced a $237 million Series E on October 23, alongside BMS and Tempus partnerships for AI-assisted drug research.
Continue Reading
Tel Aviv’s Mave announced a $28 million Series A on October 22. Its AI platform aims to connect investigations across existing security tools.
Continue Reading
Pursuit’s planned AI Jobs Institute in Queens has $10 million in public backing and a 2032 training goal. Read the timeline and current program details.
Continue Reading
Rylo announced an NVIDIA collaboration on October 21 to advance sign-language AI research. Explore the Tel Aviv connection, technical work and separate desktop captioning product.
Continue Reading